In the last few decades, significant progress has been made in both the probiotics and prebiotics fields. While probiotics were once only used to treat infections and sensitivities, they are now being used to treat a wide range of infections and diseases. A wide range of new probiotics and prebiotics are being developed, and their market in nutrition is rapidly expanding. One example is a hereditarily changed life form (i.e., a nonspecific modification of a probiotic strain) that must be generated and rigorously evaluated before being used as part of food, and whose objective is to improve desired capabilities. The research in this sector indicates that the food and wellness industries have a bright future. A slew of scientific research has emerged in recent years that reveal linkages between our gut flora and various disease risk factors and health issues. However, because much of this research is still in its early stages, many people are asking what the future holds for probiotics and prebiotics.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India